Intensive care medicine
-
Intensive care medicine · Apr 2022
Multicenter StudySurvival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study.
Extracorporeal membrane oxygenation (ECMO) has become an established therapy for severe respiratory failure in coronavirus disease 2019 (COVID-19). The added benefit of receiving ECMO in COVID-19 remains uncertain. The aim of this study is to analyse the impact of receiving ECMO at specialist centres on hospital mortality. ⋯ We found ECMO provided at specialist centres conferred significant survival benefit. Where resources and specialism allow, ECMO should be widely offered.